Pioglar MF 15 mg/500 mg Tablet
By Pioglar MF
Rx
10 Tablet in a Strip

Composition
Pioglitazone(15mg) + Metformin(500mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
May, 2026

liver
Pioglar MF 15 mg/500 mg Tablet should be used carefully by individuals with liver disease. It may be necessary to adjust the dosage of Pioglar MF 15 mg/500 mg Tablet in such cases. It is advisable to consult your doctor before starting the medication. Typically, Pioglar MF 15 mg/500 mg Tablet is initially prescribed at a low dosage for individuals with mild to moderate liver disease. However, it is not recommended for use by those with severe liver disease. It is crucial to follow your healthcare provider's guidance closely when considering this medication for liver-related issues.

kidney
Pioglar MF 15 mg/500 mg Tablet should be used carefully if you have kidney disease. Your doctor may need to adjust the dose. Avoid using this tablet if you have severe kidney disease. It's important to have regular kidney function tests while on this medication.

alcohol
It is not safe to drink alcohol while taking Pioglar MF 15 mg/500 mg Tablet.

driving
"Caution Do not drive if your blood sugar is too low or too high while taking Pioglar MF 15 mg/500 mg Tablet."

pregnancy
Pioglar MF 15 mg/500 mg Tablet may not be safe to use during pregnancy. Studies in animals have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it to you. Please consult your doctor.

breastfeeding
Pioglar MF 15 mg/500 mg Tablet may not be safe during breastfeeding. Limited data suggests it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹84
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024